These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 39349581)
1. Transcriptomic and proteomic spatial profiling of pediatric and adult diffuse midline glioma H3 K27-Altered. Damodharan S; Shireman JM; Xie E; Distler E; Kendziorski C; Dey M Sci Rep; 2024 Sep; 14(1):22668. PubMed ID: 39349581 [TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and Proteomic Spatial Profiling of Pediatric and Adult Diffuse Midline Glioma H3 K27-Altered, Reveals Region Specific Differences and Limited Overlap between mRNA and Protein. Damodharan S; Shireman JM; Xie E; Distler E; Kendziorski C; Dey M Res Sq; 2024 Apr; ():. PubMed ID: 38645012 [TBL] [Abstract][Full Text] [Related]
3. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
4. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592 [TBL] [Abstract][Full Text] [Related]
5. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location. Guidara S; Seyve A; Poncet D; Leonce C; Bringuier PP; McLeer A; Sturm D; Cartalat S; Picart T; Ferrari A; Hench J; Frank S; Meyronet D; Ducray F; Barritault M J Neurooncol; 2024 Sep; 169(2):391-398. PubMed ID: 38937309 [TBL] [Abstract][Full Text] [Related]
19. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related]
20. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies. Findlay IJ; De Iuliis GN; Duchatel RJ; Jackson ER; Vitanza NA; Cain JE; Waszak SM; Dun MD Oncogene; 2022 Jan; 41(4):461-475. PubMed ID: 34759345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]